View Filing Data

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2017	Oct. 09, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Entity Registrant Name	FLEXSTEEL INDUSTRIES INC
Entity Central Index Key	0000037472
Current Fiscal Year End Date	--06-30
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		7,845,269
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Trading Symbol	FLXS

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
ASSETS
Cash and cash equivalents	$ 33,446	$ 28,874
Investments	13,962	17,958
Trade receivables - less allowances: September 30, 2017, $1,125; June 30, 2017, $1,200	45,814	42,362
Inventories	104,223	99,397
Other	9,335	6,659
Total current assets	206,780	195,250
NONCURRENT ASSETS:
Property, plant and equipment, net	69,919	70,661
Deferred income taxes	840	1,740
Other assets	2,434	2,394
TOTAL	279,973	270,045
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable - trade	18,674	16,758
Accrued liabilities:
Payroll and related items	5,146	6,255
Insurance	5,802	5,423
Other	12,980	8,759
Total current liabilities	42,602	37,195
LONG-TERM LIABILITIES:
Other liabilities	2,268	2,090
Total liabilities	44,870	39,285
SHAREHOLDERS' EQUITY:
Stockholders' Equity, Total	235,103	230,760
Common stock - $1 par value; authorized 15,000,000 shares; outstanding September 30, 2017, 7,845,239 shares; June 30, 2017, 7,822,080 shares	7,845	7,822
Additional paid-in capital	26,046	26,186
Retained earnings	202,919	198,465
Accumulated other comprehensive loss	(1,707)	(1,713)
TOTAL	$ 279,973	$ 270,045

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Consolidated Balance Sheets [Abstract]
Trade receivables, allowance for doubtful accounts	$ 1,125	$ 1,200
Common stock, par value	$ 1	$ 1
Common stock, authorized	15,000,000	15,000,000
Common stock, outstanding	7,845,239	7,822,080

Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Consolidated Statements Of Operations [Abstract]
Net sales	$ 119,834	$ 112,050
Cost of goods sold	(93,694)	(85,420)
Gross margin	26,140	26,630
Selling, general and administrative	(18,236)	(18,926)
Gain on sale of facility	1,835
Operating income (loss)	9,739	7,704
Interest and other income	141	48
Income before income taxes	9,880	7,752
Income tax provision	(3,700)	(3,000)
Net income (loss)	$ 6,180	$ 4,752
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING:
Basic	7,830	7,725
Diluted	7,937	7,838
EARNINGS (LOSS) PER SHARE OF COMMON STOCK:
Basic	$ 0.79	$ 0.62
Diluted	$ 0.78	$ 0.61

Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss) [Abstract]
Net income	$ 6,180	$ 4,752
Unrealized (losses) gains on securities	(25)	61
Reclassification of realized gain to other income	35	20
Other Comprehensive Income (Loss) Before Taxes	10	81
Income tax benefit (expense) related to securities gains (losses)	(4)	(31)
Other comprehensive (loss) income, net of tax	6	50
Comprehensive income	$ 6,186	$ 4,802

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES:
Net income (loss)	$ 6,180	$ 4,752
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation	1,847	2,032
Deferred income taxes	896	699
Stock-based compensation expense	353	639
Excess tax benefit from stock-based payment arrangements		(1,034)
Provision for losses on accounts receivable	(75)	(100)
Gain on disposition of capital assets	(1,842)	(63)
Changes in operating assets and liabilities:
Trade receivables	(3,377)	1,884
Inventories	(4,826)	(794)
Other current assets	(436)	1,247
Other assets		(133)
Accounts payable - trade	1,576	2,307
Accrued liabilities	1,089	346
Other long-term liabilities	147	(548)
Net cash provided by operating activities	1,532	11,234
INVESTING ACTIVITIES:
Purchases of investments	(8,022)	(790)
Proceeds from sales of investments	12,020	768
Proceeds from sale of capital assets	6,152	63
Capital expenditures	(5,075)	(4,491)
Net cash (used in) provided by investing activities	5,075	(4,450)
FINANCING ACTIVITIES:
Dividends paid	(1,565)	(1,386)
Proceeds from issuance of common stock	3	588
Shares withheld for employee tax obligations	(473)	(1,132)
Excess Tax Benefit from Share-based Compensation, Financing Activities		(1,034)
Net cash used in financing activities	(2,035)	(896)
Increase (decrease) in cash and cash equivalents	4,572	5,888
Cash and cash equivalents at beginning of year	28,874	36,780
Cash and cash equivalents at end of year	33,446	42,668
SUPPLEMENTAL INFORMATION CASH PAID DURING THE PERIOD FOR:
Income taxes paid (refunded)	115	(1,224)
Capital Expenditures Incurred but Not yet Paid	$ 2,080	$ 2

Summary Of Significant Accounting Policies

3 Months Ended

Sep. 30, 2017

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

The consolidated financial statements included herein have been prepared by Flexsteel Industries, Inc. and Subsidiaries (the “Company” or “Flexsteel”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished in the consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which are, in the opinion of management, necessary for a fair presentation of such consolidated financial statements. Operating results for the three months ended September 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2018. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. Except to the extent updated or described below, the significant accounting policies set forth in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2017, appropriately represent, in all material respects, the current status of accounting policies and are incorporated by reference.

DESCRIPTION OF BUSINESS – Flexsteel was incorporated in 1929 and is one of the oldest and largest manufacturers, importers and marketers of residential and commercial upholstered and wooden furniture products in the United States. Product offerings include a wide variety of upholstered and wooden furniture such as sofas, loveseats, chairs, reclining and rocker-reclining chairs, swivel rockers, sofa beds, convertible bedding units, occasional tables, desks, dining tables and chairs and bedroom furniture. The Company’s products are intended for use in home, office, hotel, healthcare and other commercial applications. A featured component in most of the upholstered furniture is a unique steel drop-in seat spring from which our name “Flexsteel” is derived. The Company distributes its products throughout the United States through the Company’s sales force and various independent representatives.

Inventories

3 Months Ended

Sep. 30, 2017

Inventories [Abstract]

Inventories

2. INVENTORIES

A comparison of inventories is as follows:



(in thousands)	September 30,		June 30,
	2017		2017
Raw materials	$	13,940	$	15,043
Work in process and finished parts		7,399		7,047
Finished goods		82,884		77,307
Total	$	104,223	$	99,397

Fair Value Measurements

3 Months Ended

Sep. 30, 2017

Fair Value Measurements [Abstract]

Fair Value Disclosures [Text Block]

3. FAIR VALUE MEASUREMENTS

The Company’s cash, investments, accounts receivable, other current assets, accounts payable, notes payable and certain accrued liabilities are carried at amounts which reasonably approximate their fair value due to their short-term nature. Generally accepted accounting principles on fair value measurement for certain financial assets and liabilities require that each asset and liability carried at fair value be classified into one of the following categories: Level 1: Quoted market prices in active markets for identical assets and liabilities; Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data; or Level 3: Unobservable inputs that are not corroborated by market data. The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period.

During the quarter ended September 30, 2017, the Company purchased available-for-sale securities, U.S. Treasury bills and U.S. Agencies, which are recorded at fair market value. These securities are classified as “Investments” in the consolidated balance sheets. Unrealized gains or losses are recorded in “Accumulated other comprehensive loss” in the consolidated balance sheets. As of September 30, 2017, the fair market value and book value of the investments are $14.0 million. As of June 30, 2017, the fair market value and book value of the investments were $18.0 million. These assets are classified as Level 1 in accordance with fair value measurements described above.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Credit Arrangements	3 Months Ended
Credit Arrangements	Sep. 30, 2017
Credit Arrangements [Abstract]
Credit Arrangements	4. CREDIT ARRANGEMENTS The Company maintains an unsecured credit agreement that provides short-term working capital financing up to $10.0 million with interest of LIBOR plus 1% (2.23% at September 30, 2017), including up to $4.0 million of letters of credit. Letters of credit outstanding at September 30, 2017 totaled $1.3 million. Other than the outstanding letters of credit, the Company did not utilize borrowing availability under the credit facility, leaving borrowing availability of $8.7 million as of September 30, 2017. The credit agreement expires June 30, 2018. At September 30, 2017, the Company was in compliance with all of the financial covenants contained in the credit agreement. The Company maintains an additional unsecured $10.0 million line of credit, with interest at prime minus 2% (2.25% at September 30, 2017). No amount was outstanding on the line of credit at September 30, 2017. This line of credit matures December 31, 2017.

Stock-Based Compensation

3 Months Ended

Sep. 30, 2017

Stock-Based Compensation [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATION

The Company has two stock-based compensation methods available when determining employee compensation.

(1)Long-Term Incentive Compensation Plans

Long-Term Incentive Compensation Plan

The long-term incentive compensation plan provides for shares of common stock to be awarded to officers and key employees based on performance targets set by the Compensation Committee of the Board of Directors (the “Committee”). the Company’s shareholders previously approved 700,000 shares to be issued under the plan. As of September 30, 2017, 92,508 shares have been issued. The committee selected fully-diluted earnings per share as the performance goal for the three-year performance periods July 1, 2015 – June 30, 2018 (2016-2018), July 1, 2016 – June 30, 2019 (2017-2019) and July 1, 2017 – June 30, 2020 (2018-2020). The Committee selected fully-diluted earnings per share and total shareholder return as a performance goal for the executive officers for the three-year performance periods 2017-2019 and 2018-2020. Stock awards will be issued to participants as soon as practicable following the end of the performance periods subject to verification of results and Committee approval. The compensation cost related to the number of shares to be granted under each performance period is fixed on the grant date, which is the date the performance period begins.

During the quarter ended September 30, 2017, the Company recorded no plan expense. During the quarter ended September 30, 2016, the Company recorded expense of $0.2 million. If the target performance goals for 2016-2018, 2017-2019 and 2018-2020 would be achieved, the total amount of compensation cost recognized over the requisite performance periods would be $1.0 million, $1.1 million and $0.8 million, respectively.

(2)Stock Plans

Omnibus Stock Plan

The Omnibus Stock Plan is for key employees, officers and directors and provides for the granting of incentive and nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights and performance units. The Company’s shareholders previously approved 700,000 shares to be issued under the plan.

Under the plan, options were granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. All options were exercisable when granted. It is the Company’s policy to issue new shares upon exercise of stock options. The Company accepts shares of the Company’s common stock as payment for the exercise price of options. Shares received as payment are retired upon receipt. During the quarters ended September 30, 2017 and 2016, the Company issued options for 21,439 and 24,317 common shares and recorded expense of $0.2 million and $0.3 million related to stock option grants, respectively.

Under the plan, the Company issued 1,863 and 1,778 shares to non-executive directors as compensation and recorded expense of $0.1 million during the quarters ended September 30, 2017 and 2016.

At September 30, 2017, 513,644 shares were available for future grants.

2006 and 2009 Stock Option Plans

The stock option plans were for key employees, officers and directors and provided for granting incentive and nonqualified stock options. Under the plans, options were granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. All options were exercisable when granted. No additional options can be granted under the 2006 and 2009 stock option plans.

There were no options granted and no expense recorded under these Plans during the three months ended September 30, 2017 and 2016.

A summary of the status of the Company’s stock plans as of September 30, 2017, June 30, 2017 and 2016, and the changes during the periods then ended is presented below:



			Weighted		Aggregate
	Shares		Average		Intrinsic Value
	(in thousands)		Exercise Price		(in thousands)
Outstanding and exercisable at June 30, 2016	270	$	22.85	$	4,638
Granted	24		47.45
Exercised	(98)		20.57
Canceled	(9)		20.51
Outstanding and exercisable at June 30, 2017	187	$	27.21	$	5,039
Granted	21		45.21
Exercised	-		-
Canceled	(5)		39.53
Outstanding and exercisable at September 30, 2017	203	$	28.77	$	4,457

The following table summarizes information for options outstanding and exercisable at September 30, 2017:



		Options
		Outstanding and	Weighted Average
	Range of	Exercisable	Remaining		Exercise
	Prices	(in thousands)	Life (Years)		Price
$	6.96 - 13.90	38	2.1	$	12.13
	17.23 - 19.77	34	4.2		18.54
	20.50 - 27.57	39	5.8		25.69
	31.06 - 32.13	32	7.2		31.62
	43.09 - 47.45	60	8.9		45.42
$	6.96 - 47.45	203	6.0	$	28.77

In March 2016, the FASB issued Improvements to Employee Share-Based Payment Accounting (ASU 2016-09), which amends ASC Topic 718, Compensation – Stock Compensation. ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. During the quarter ended September 30, 2017, the Company adopted ASU 2016-09. Excess tax benefits from share-based compensation are included within net income and accrued liabilities as part of operating activities in the statement of cash flows and are no longer included as a financing activity. This change is applied prospectively. The standard allows for an accounting policy election to account for forfeitures as an estimate or to account for forfeitures as they occur. The Company elected to continue estimating the number of awards expected to be forfeited and adjust the estimate on an ongoing basis.

For the quarter ended September 30, 2017, the Company recognized net tax benefits related to share-based compensation awards of $0.1 million as a reduction of income tax expense in the consolidated statements of income. The impact of this change for the prior year quarter ended September 30, 2016 would have been a reduction of income tax expense of $1.0 million. Prior to adoption, these items were recorded in additional paid-in capital in the consolidated balance sheets.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

Earnings Per Share

3 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

Basic earnings per share (EPS) of common stock are based on the weighted-average number of common shares outstanding during each period. Diluted earnings per share of common stock include the dilutive effect of potential common shares outstanding. The Company’s potential common shares outstanding are stock options, shares associated with the long-term management incentive compensation plan and non-vested shares. The Company calculates the dilutive effect of outstanding options using the treasury stock method. Anti-dilutive shares are not included in the computation of diluted EPS when their exercise price is greater than the average closing market price of the common shares. The Company calculates the dilutive effect of shares related to the long-term management incentive compensation plan and non-vested shares based on the number of shares, if any, that would be issuable if the end of the fiscal period were the end of the contingency period.

In computing EPS for the quarter ended September 30, 2017 and 2016, net income as reported for each respective period is divided by the fully diluted weighted-average number of shares outstanding:



	Three Months Ended
	September 30,
(in thousands)	2017	2016

Basic shares	7,830	7,725

Potential common shares:
Stock options	89	111
Long-term incentive plan	16	-
Non-vested shares	2	2
	107	113

Diluted shares	7,937	7,838

Anti-dilutive shares	-	24

Cash dividends declared per common share were $0.22 and $0.20 for the quarters ended September 30, 2017 and 2016, respectively.

Litigation	3 Months Ended
Litigation	Sep. 30, 2017
Litigation [Abstract]
Litigation	7. LITIGATION Environmental Matters – In March 2016, the Company received a General Notice Letter for the Lane Street Groundwater Superfund Site located in Elkhart, Indiana from the United States Environmental Protection Agency (EPA). In April 2016, the EPA issued their proposed clean-up plan for groundwater pollution and request for public comment. The Company responded to the request for public comment in May 2016. The EPA issued a Record of Decision selecting a remedy in August 2016 and estimated total costs to remediate of $3.6 million. In July 2017, the EPA issued a Special Notice Letter to the Company demanding that the Company perform the remedy selected and pay for the remediation cost and past response costs of $5.5 million. Based on extensive sampling investigation performed on behalf of the Company, the Company believes that the source of the ground water contamination is upgradient of the site formerly owned by the Company. The Company continues to believe that it did not cause or contribute to the contamination. On October 12, 2017, the Company, after consultation with its insurance carriers, offered an amount, fully reimburseable by insurance coverage, to the EPA to resolve this matter. Other Proceedings – From time to time, the Company is subject to various other legal proceedings, including lawsuits, which arise out of, and are incidental to, the conduct of the Company’s business. The Company does not consider any of such other proceedings that are currently pending, individually or in the aggregate, to be material to its business or likely to result in a material effect on its consolidated operating results, financial condition, or cash flows.

Subsequent Event	3 Months Ended
Subsequent Event	Sep. 30, 2017
Subsequent Events [Abstract]
Subsequent Event	As of October 23, 2017, there were no subsequent events other than the item disclosed in Footnote 7.

Inventories (Tables)

3 Months Ended

Sep. 30, 2017

Inventories [Abstract]

Comparison Of Inventories



(in thousands)	September 30,		June 30,
	2017		2017
Raw materials	$	13,940	$	15,043
Work in process and finished parts		7,399		7,047
Finished goods		82,884		77,307
Total	$	104,223	$	99,397

Stock-Based Compensation (Tables)

3 Months Ended

Sep. 30, 2017

Stock-Based Compensation [Abstract]

Schedule Of Stock Option Plans



			Weighted		Aggregate
	Shares		Average		Intrinsic Value
	(in thousands)		Exercise Price		(in thousands)
Outstanding and exercisable at June 30, 2016	270	$	22.85	$	4,638
Granted	24		47.45
Exercised	(98)		20.57
Canceled	(9)		20.51
Outstanding and exercisable at June 30, 2017	187	$	27.21	$	5,039
Granted	21		45.21
Exercised	-		-
Canceled	(5)		39.53
Outstanding and exercisable at September 30, 2017	203	$	28.77	$	4,457

Schedule Of Options Outstanding And Exercisable



		Options
		Outstanding and	Weighted Average
	Range of	Exercisable	Remaining		Exercise
	Prices	(in thousands)	Life (Years)		Price
$	6.96 - 13.90	38	2.1	$	12.13
	17.23 - 19.77	34	4.2		18.54
	20.50 - 27.57	39	5.8		25.69
	31.06 - 32.13	32	7.2		31.62
	43.09 - 47.45	60	8.9		45.42
$	6.96 - 47.45	203	6.0	$	28.77

Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted



	Three Months Ended
	September 30,
(in thousands)	2017	2016

Basic shares	7,830	7,725

Potential common shares:
Stock options	89	111
Long-term incentive plan	16	-
Non-vested shares	2	2
	107	113

Diluted shares	7,937	7,838

Anti-dilutive shares	-	24

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Inventories [Abstract]
Total inventories	$ 104,223	$ 99,397
Raw materials, net of reserves	13,940	15,043
Work in process and finished parts, net of reserves	7,399	7,047
Finished goods, net of reserves	$ 82,884	$ 77,307

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Fair Value Measurements [Abstract]
Investments	$ 13,962	$ 17,958

Credit Arrangements (Details) $ in Millions	3 Months Ended
Credit Arrangements (Details) $ in Millions	Sep. 30, 2017 USD ($)
Line of Credit Facility [Line Items]
Credit agreement capacity	$ 10.0
Interest rate over LIBOR	1.00%
Libor Plus 1 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.23%
Prime Minus 2 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.25%
Letter Of Credit [Member]
Line of Credit Facility [Line Items]
Credit agreement capacity	$ 4.0
Line of Credit Facility, Amount Outstanding	1.3
Line of Credit Facility, Remaining Borrowing Capacity	8.7
Unsecured [Member]
Line of Credit Facility [Line Items]
Credit agreement capacity	$ 10.0
Interest rate under prime rate	2.00%

Stock-Based Compensation (Narrative) (Details) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Adjustments for New Accounting Pronouncement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Excess tax benefit from stock-based payment arrangements		$ 1,000,000
Other Tax Expense (Benefit)	$ 100,000
Stock Option Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued	0	0
Compensation cost	$ 0	$ 0
Period options are excercisable	10 years
Shares available for future grants	0
New Long-Term Management Incentive Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares approved to be issued under plan	700,000
Shares issued	92,508
Compensation cost	$ 0	200,000
New Long-Term Management Incentive Compensation Plan [Member] \| 2016-2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	1,000,000
New Long-Term Management Incentive Compensation Plan [Member] \| 2017-2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	1,100,000
New Long-Term Management Incentive Compensation Plan [Member] \| 2018-2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 800,000
New Omnibus Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares approved to be issued under plan	700,000
Compensation cost	$ 200,000	$ 300,000
Period options are excercisable	10 years
Options issued under stock option plans	21,439	24,317
Shares available for future grants	513,644
New Omnibus Stock Plan [Member] \| Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued	1,863	1,778
Compensation cost	$ 100,000	$ 100,000

Stock-Based Compensation (Schedule Of Stock Option Plans) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Stock-Based Compensation [Abstract]
Shares, Outstanding and exercisable	187	270
Shares, Granted	21	24
Shares, Exercised		(98)
Shares, Canceled	(5)	(9)
Shares, Outstanding and exercisable	203	187
Weighted Average Exercise Price, Oustanding and exercisable	$ 27.21	$ 22.85
Weighted Average Exercise Price, Granted	45.21	47.45
Weighted Average Exercise Price, Exercised		20.57
Weighted Average Exercise Price, Canceled	39.53	20.51
Weighted Average Exercise Price, Oustanding and exercisable	$ 28.77	$ 27.21
Aggregate Intrinsic Value	$ 4,457	$ 5,039	$ 4,638

Stock-Based Compensation (Schedule Of Options Outstanding And Exercisable) (Details) shares in Thousands	3 Months Ended
	Sep. 30, 2017 $ / shares shares
6.96 - 13.90 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Range of Price Lower	$ 6.96
Range of Price Upper	$ 13.90
Options Outstanding \| shares	38
Weighted Average Remaining Life, Years	2 years 1 month 6 days
Weighted Average Exercise Price	$ 12.13
17.23 - 19.77 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Range of Price Lower	17.23
Range of Price Upper	$ 19.77
Options Outstanding \| shares	34
Weighted Average Remaining Life, Years	4 years 2 months 12 days
Weighted Average Exercise Price	$ 18.54
20.50 - 27.57 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Range of Price Lower	20.50
Range of Price Upper	$ 27.57
Options Outstanding \| shares	39
Weighted Average Remaining Life, Years	5 years 9 months 18 days
Weighted Average Exercise Price	$ 25.69
31.06 - 32.13 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Range of Price Lower	31.06
Range of Price Upper	$ 32.13
Options Outstanding \| shares	32
Weighted Average Remaining Life, Years	7 years 2 months 12 days
Weighted Average Exercise Price	$ 31.62
43.09 - 47.45 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Range of Price Lower	43.09
Range of Price Upper	$ 47.45
Options Outstanding \| shares	60
Weighted Average Remaining Life, Years	8 years 10 months 24 days
Weighted Average Exercise Price	$ 45.42
6.96 - 47.45 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Range of Price Lower	6.96
Range of Price Upper	$ 47.45
Options Outstanding \| shares	203
Weighted Average Remaining Life, Years	6 years
Weighted Average Exercise Price	$ 28.77

Litigation (Details) - USD ($) $ in Millions	Jul. 31, 2017	Aug. 31, 2016
Litigation [Abstract]
Loss Contingency, Estimate of Possible Loss	$ 5.5	$ 3.6

Earnings Per Share (Details) - $ / shares shares in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Earnings Per Share [Abstract]
Basic	7,830	7,725
Stock options	89	111
Long-term incentive plan	16
Restricted shares	2	2
Potential common shares, total	107	113
Diluted	7,937	7,838
Anti-dilutive shares		24
Dividends declared per common share	$ 0.22	$ 0.20